Tobias Welponer
Salzburg, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Meta-Analysis of Pain Management in Epidermolysis Bullosa.
Journal: The British journal of dermatology
Published: October 14, 2025
Patient-reported outcomes during pregnancy and delivery in epidermolysis bullosa.
Journal: BMC pregnancy and childbirth
Published: August 18, 2025
Keratin-associated epidermolysis bullosa simplex: phenotypes and challenges in clinical trials - a narrative review and systematic update.
Journal: Orphanet journal of rare diseases
Published: January 28, 2025
Core outcome domain sets for clinical trials in epidermolysis bullosa - a COSEB protocol to achieve consensus on "what" to measure.
Journal: Trials
Published: October 15, 2024
Systematic review on antipruritic therapies for patients with Epidermolysis bullosa.
Journal: The Journal of dermatological treatment
Published: July 28, 2024
Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa.
Journal: The British journal of dermatology
Published: April 02, 2024
Neurofibromatosis type 1 adult surveillance form for Austria.
Journal: Wiener klinische Wochenschrift
Published: March 18, 2024
Translation, cultural adaptation and validation of the German Quality of Life in Epidermolysis Bullosa (QOLEB) questionnaire.
Journal: Journal of health psychology
Published: February 19, 2024
Harmonization of outcomes in epidermolysis bullosa: report of the Core Outcome Sets for Epidermolysis Bullosa (COSEB) kick-off meeting.
Journal: The British journal of dermatology
Published: August 07, 2023
Metformin shows anti-neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa-associated aggressive cutaneous squamous cell carcinoma.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: March 28, 2023
Nivolumab for locally advanced and metastatic cutaneous squamous cell carcinoma (NIVOSQUACS study)-Phase II data covering impact of concomitant haematological malignancies.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 07, 2023
Heterogeneity of reported outcomes in epidermolysis bullosa clinical research: a scoping review as a first step towards outcome harmonization.
Journal: The British journal of dermatology
Published: December 01, 2022
Last Updated: 09/26/2026